Every 8-K that CH4 Natural Solutions Corporation (MTNE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow MTNE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MTNE filings page.
CH4 Natural Solutions Corporation announced that, commencing June 22, 2026, holders of its NYSE-listed units may elect to separately trade the Class A ordinary shares and warrants included in those units. Units will continue trading under “MTNE.U,” while separated Class A shares and warrants will trade under “MTNE” and “MTNE.WS,” respectively. Each unit contains a Class A ordinary share with $0.0001 par value and one-half of one warrant, and each whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50 per share. No fractional warrants will be issued upon separation.
CH4 Natural Solutions Corporation reports completion of its initial public offering and a partial over-allotment exercise, together with a related private placement. The IPO comprised 20,000,000 units at $10.00 per unit and the underwriter later purchased 2,000,000 additional over-allotment units at the same price. A separate private placement of 200,000 units at $10.00 per unit generated an extra $2,000,000. In total, $220,000,000, including deferred underwriting discounts and commissions, was deposited into a trust account for the benefit of shareholders. The accompanying unaudited pro forma balance sheet as of May 8, 2026 shows 22,000,000 Class A ordinary shares subject to possible redemption at $10.00 per share and records related deferred underwriting fees, advisory fees, and over-allotment option adjustments.
CH4 Natural Solutions Corporation completed its initial public offering of 20,000,000 units at $10.00 each, raising $200,000,000, and a simultaneous private placement of 200,000 units for $2,000,000. The underwriter later purchased an additional 2,000,000 units, bringing total cash held in the Trust Account to $220,000,000, including deferred underwriting commissions. Each unit includes one Class A ordinary share and one-half warrant exercisable at $11.50 per share. The audited balance sheet shows cash held in the Trust Account of $200,000,000 as of May 4, 2026 and a shareholders’ deficit driven by $200,000,000 of Class A ordinary shares classified as redeemable. The auditor issued an unqualified opinion but highlighted substantial doubt about the Company’s ability to continue as a going concern due to limited working capital outside the Trust Account until a business combination is completed.